About:

HPV or Human Papillomavirus Infection is the most common sexually transmitted infection in the United States, according to the CDC. About 79 million Americans are currently infected and about 14 million people become newly infected each year. It easily spreads from sexual skin-to-skin contact with someone who has it. Most people who are sexually active, will get it at some point in their lives, without even knowing, as symptoms often can go unnoticed. For people that have HPV, it can result in deadly cancers including cervical, neck and head cancer.

Each year, 12,000 women living in the US will be diagnosed with cervical cancer due to HPV. 1/3 (or 4,000 women) will die from cervical cancer, even with screening and treatment. There are other cancers caused by HPV that occur in the US as well which affects approximately 19,400 women and 12,000 men.

Prevention:

The best prevention method is to get vaccinated. The HPV vaccine (Gardasil) has been proven to be safe and effective. It can protect against the disease itself as well as cancers that are caused by HPV. Currently, there is no cure.

How you can help advance medicine and change lives through research:

Rochester Clinical Research is currently conducting a research study with the FDA approved vaccine Gardasil. This study will help prove that Gardasil not only prevents genital warts and cervical cancer, but also head and neck cancers caused by the same HPV virus. If you are a man between the ages of 20 – 45, and have never been vaccinated for it, click here to learn more about this research study opportunity and to see if you qualify. Compensation for study participation is available up to $1,150.

Men’s HPV Vaccine

The purpose of this research study is to determine the efficacy and safety of a 3-dose HPV vaccine in males between the ages of 20- 45. The vaccine aims to prevent HPV infection which are associated with oral cancer. Compensation is available up to $1,300, for those who qualify.

View Trial Details
Ages 20 – 45
Gender For male patients only
Compensation* $1,300
Study Topics Vaccine

*Compensation for time and travel may be available to those who qualify.